Patrick G. LePore is a businessperson who has been at the head of 6 different companies and currently holds the position of Independent Non-Executive Chairman at Lannett Co., Inc., Chairman at Lautus Pharmaceuticals LLC and Chairman at Endo Generics Holdings, Inc. He is also on the board of Matinas BioPharma Holdings, Inc., Villanova University, Tyme, Inc. and VYNE Therapeutics, Inc.
In his past career Patrick G. LePore occupied the position of Chairman for AgeneBio, Inc., President-Healthcare Marketing Group at Cardinal Health, Inc. and Chairman, President & Chief Executive Officer at Boron, LePore & Associates, Inc. (a subsidiary of Cardinal Health, Inc.) and Chairman, President & Chief Executive Officer of Par Pharmaceutical, Inc.
Patrick G. LePore received an undergraduate degree from Villanova University and an MBA from Fairleigh Dickinson University.
What is Patrick G. LePore's net worth?
The estimated net worth of Patrick G. LePore is at least $102,851.04 as of November 15th, 2023. Mr. LePore owns 36,472 shares of VYNE Therapeutics stock worth more than $102,851 as of November 21st. This net worth evaluation does not reflect any other investments that Mr. LePore may own. Learn More about Patrick G. LePore's net worth.
How do I contact Patrick G. LePore?
Has Patrick G. LePore been buying or selling shares of VYNE Therapeutics?
Patrick G. LePore has not been actively trading shares of VYNE Therapeutics during the last ninety days. Most recently, on Wednesday, November 15th, Patrick G. Lepore bought 13,000 shares of VYNE Therapeutics stock. The stock was acquired at an average cost of $3.91 per share, with a total value of $50,830.00. Following the completion of the transaction, the director now directly owns 36,472 shares of the company's stock, valued at $142,605.52. Learn More on Patrick G. LePore's trading history.
